Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131898) titled 'Clinical Study on Qihong Tongnao Mixture in the Treatment of Acute Ischemic Stroke (Qi Deficiency and Blood Stasis Syndrome)' on Sept. 7.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine
Condition:
Cerebral arterial thrombosis
Intervention:
Trial group:Conventional Western medicine-based basic treatment + Qihong Tongna Compound
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-07
Target Sample Size: Trial group:54;Control group:54;
Countries of Recruitmen...